124 related articles for article (PubMed ID: 37724950)
1. Evaluation of genetic variants in ferroptosis-related genes and house dust mite-induced allergic rhinitis risk.
Yang YF; Zheng R; Gu X; Gao F; Chen M; Du ML; Zhang ZD; Lu MP; Cheng L
Int Immunopharmacol; 2023 Feb; 115():109707. PubMed ID: 37724950
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in Hippo pathway genes are associated with house dust mite-induced allergic rhinitis in a Chinese population.
Chen M; Zheng R; Li F; Xin JY; Chen SL; Zhu XJ; Gu X; Dai MD; Yang YF; Chu HY; Zhang ZD; Lu MP; Cheng L
Clin Transl Allergy; 2021 Dec; 11(10):e12077. PubMed ID: 34962722
[TBL] [Abstract][Full Text] [Related]
3. GWAS-identified variants to allergic disease and early environmental exposure in Chinese schoolchildren with allergic rhinitis induced by house dust mite.
Li Y; Lin Y; Jiang Y; Rui X; Ma B; Li J
Asian Pac J Allergy Immunol; 2022 Mar; 40(1):55-64. PubMed ID: 33274951
[TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1*08:03:02 and HLA-DQB1*06:01:01 are associated with house dust mite-sensitive allergic rhinitis in Chinese subjects.
Zhao Y; Zhao Y; Li J; Zhang Y; Zhang L
Int Forum Allergy Rhinol; 2016 Aug; 6(8):854-61. PubMed ID: 27013183
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
6. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the TLR4 rs1927911 polymorphism with house dust mite sensitization in allergic rhinitis with its prognosis.
Lee E; Lee SY; Park MJ; Hong SJ
Asian Pac J Allergy Immunol; 2023 Jun; 41(2):133-141. PubMed ID: 33386789
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
10. House Dust Mite Related Allergic Rhinitis and REM Sleep Disturbances.
Berson SR; Klimczak JA; Prezio EA; Abraham MT
Am J Otolaryngol; 2020; 41(6):102709. PubMed ID: 32866850
[TBL] [Abstract][Full Text] [Related]
11. Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS.
Kojima R; Shinohara R; Kushima M; Horiuchi S; Otawa S; Miyake K; Yokomichi H; Akiyama Y; Ooka T; Yamagata Z; The Japan Environment And Children's Study Group
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429515
[TBL] [Abstract][Full Text] [Related]
12. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.
Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C
Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
14.
Chen XY; Zhu XJ; Chen M; Lu MP; Wang ML; Yin M; Chen RX; Wu ZF; Bu DY; Zhang ZD; Cheng L
J Asthma Allergy; 2022; 15():1369-1381. PubMed ID: 36196093
[TBL] [Abstract][Full Text] [Related]
15. House dust mite sublingual immunotherapy in allergic rhinitis.
Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
[TBL] [Abstract][Full Text] [Related]
16. Association between DNA hypomethylation at IL13 gene and allergic rhinitis in house dust mite-sensitized subjects.
Li JY; Zhang Y; Lin XP; Ruan Y; Wang Y; Wang CS; Zhang L
Clin Exp Allergy; 2016 Feb; 46(2):298-307. PubMed ID: 26399722
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
18. Functional variants of 17q12-21 are associated with allergic asthma but not allergic rhinitis.
Andiappan AK; Sio YY; Lee B; Suri BK; Matta SA; Lum J; Foo S; Koh G; Liu J; Zolezzi F; Poidinger M; Wang de Y; Rotzschke O; Chew FT
J Allergy Clin Immunol; 2016 Mar; 137(3):758-66.e3. PubMed ID: 26483175
[TBL] [Abstract][Full Text] [Related]
19. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
Steelant B; Farré R; Wawrzyniak P; Belmans J; Dekimpe E; Vanheel H; Van Gerven L; Kortekaas Krohn I; Bullens DMA; Ceuppens JL; Akdis CA; Boeckxstaens G; Seys SF; Hellings PW
J Allergy Clin Immunol; 2016 Apr; 137(4):1043-1053.e5. PubMed ID: 26846377
[TBL] [Abstract][Full Text] [Related]
20. Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects.
Hasegawa A; Utsumi D; Lund K; Okano M; Ohashi-Doi K; Okubo K
Int Immunopharmacol; 2022 Jun; 107():108640. PubMed ID: 35217338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
